Chronic metformin associated cardioprotection against infarction: not just a glucose lowering phenomenon. (Q42516922)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192487%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

title

Chronic metformin associated cardioprotection against infarction: not just a glucose lowering phenomenon (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192487%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

0 references

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192487%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Andrew R Hall

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192487%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

5

Derek M Yellon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192487%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

6

Mihaela M Mocanu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192487%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1

Hannah J Whittington

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192487%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Catarina P McLaughlin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192487%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

publication date

1 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192487%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular Drugs and Therapy

19 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192487%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192487%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192487%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

5-16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192487%20AND%20SRC:MED&resulttype=core&format=json

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

19 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Diabetes and cardiovascular disease: the road to cardioprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Mechanism by which metformin reduces glucose production in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Increased PTEN expression due to transcriptional activation of PPARgamma by Lovastatin and Rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Metformin increases the PGC-1alpha protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

PGC-1alpha: a key regulator of energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Alterations in the mitochondrial regulatory pathways constituted by the nuclear co-factors PGC-1alpha or PGC-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Aging and cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

PGC-1alpha in aging and anti-aging interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Mitochondria and PGC-1α in Aging and Age-Associated Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Animal models of diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Vascular protection in diabetic stroke: role of matrix metalloprotease-dependent vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

One hour reperfusion is enough to assess function and infarct size with TTC staining in Langendorff rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Dynamic regulation of PGC-1alpha localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Metformin improves vascular function in insulin-resistant rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Transitory activation of AMPK at reperfusion protects the ischaemic-reperfused rat myocardium against infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Does long-term metformin treatment increase cardiac lipoprotein lipase?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Metformin therapy and clinical uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

AMP-activated protein kinase in the control of cardiac metabolism and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

An energetic tale of AMPK-independent effects of metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Mitochondrial dynamics in mammalian health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6425-X

10.1007/S10557-012-6425-X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23192487%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference